EUVIMEDEUVIMED entdecken
Metaanalyse

Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials

Xue-Jie Lou, Di Qiu, Zhuo-Yu Ren, Kenji Hashimoto, Guang-Fen Zhang, Jian-Jun Yang

Asian Journal of Psychiatry · 2024-05 · 95 · 103997

DOI: 10.1016/j.ajp.2024.103997 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Asian Journal of Psychiatry, 2024-05. Verfasst von Xue-Jie Lou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Pain and Perioperative Medicine, The first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China. Hauptthemen laut MEDLINE: Depression, Elective Surgical Procedures, Ketamine, Postoperative Complications. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Depression is a prevalent mood disorder during the perioperative period, with both preoperative concurrent depression and new-onset postoperative depression impacting postoperative recovery. Recent studies have indicated that the dissociative anesthetic esketamine may alleviate perioperative depressive symptoms. OBJECTIVE: This meta-analysis aimed to assess the efficacy and safety of esketamine in treating perioperative depression. METHODS: We selected randomized controlled trials comparing esketamine to placebo in terms of postoperative depressive symptoms. The primary outcome was postoperative depression scores, with secondary outcomes including the prevalence of postoperative depression, pain scores using the Visual Analogue Scale or Numeric Rating Scale, and incidences of adverse reactions such as nausea/vomiting, dizziness, dreams/nightmares, hallucinations. RESULTS: We enrolled a total of 17 studies involving 2462 patients. The esketamine group demonstrated a significant reduction in postoperative depression scores within one week after surgery (SMD -0.47, 95% CI (-0.66, -0.27), P < 0.001) and over the long term (SMD -0.44, 95% CI (-0.79, -0.09), P = 0.01). Furthermore, esketamine significantly decreased the prevalence of postoperative depression both within one week (RR 0.46, 95% CI (0.33, 0.63), P < 0.001) and over the long term (RR 0.50, 95% CI (0.36, 0.70), P < 0.001). Additionally, esketamine effectively relieved pain on the first postoperative day compared to control. However, it also increased the risks of dizziness and hallucinations for a short time. CONCLUSION: This meta-analysis suggests that the intraoperative or postoperative application of esketamine could be a potentially effective treatment for perioperative depression, although the increased risk of adverse reactions should be considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionElective Surgical ProceduresKetaminePostoperative ComplicationsHumansPerioperative PeriodRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

DepressionDizzinessEsketamineHallucinationPainPerioperative

Substanzen

EsketamineKetamine

Autor:innen und Institutionen

  • Department of Anesthesiology, Pain and Perioperative Medicine, The first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Department of Anesthesiology, Pain and Perioperative Medicine, The first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China; Division of Clinical Neuroscience, Chiba University Center for Forens…
  • Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China. Electronic address: wfzhgf87@126.com.
  • Department of Anesthesiology, Pain and Perioperative Medicine, The first Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China. Electronic address: yjyangjj@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lou, X. J., Qiu, D., Ren, Z. Y., Hashimoto, K., Zhang, G. F., & Yang, J. J. (2024). Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials. Asian Journal of Psychiatry, 95, 103997. https://doi.org/10.1016/j.ajp.2024.103997

Vancouver

Lou XJ, Qiu D, Ren ZY, Hashimoto K, Zhang GF, Yang JJ. Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials. Asian Journal of Psychiatry. 2024;95:103997. doi:10.1016/j.ajp.2024.103997

BibTeX
@article{Lou2024,
  author = {Lou, Xue-Jie and Qiu, Di and Ren, Zhuo-Yu and Hashimoto, Kenji and Zhang, Guang-Fen and Yang, Jian-Jun},
  title = {Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials},
  journal = {Asian Journal of Psychiatry},
  year = {2024},
  volume = {95},
  pages = {103997},
  doi = {10.1016/j.ajp.2024.103997}
}
Kostenlos starten →